ETC
Exchange Traded Concepts’s NovoCure NVCR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $743K | Buy |
41,716
+3,904
| +10% | +$69.5K | 0.01% | 796 |
|
|
2025
Q1 | $674K | Buy |
37,812
+9,001
| +31% | +$160K | 0.01% | 728 |
|
|
2024
Q4 | $859K | Sell |
28,811
-19,616
| -41% | -$585K | 0.02% | 619 |
|
|
2024
Q3 | $757K | Buy |
48,427
+8,272
| +21% | +$129K | 0.02% | 653 |
|
|
2024
Q2 | $688K | Sell |
40,155
-18,775
| -32% | -$322K | 0.02% | 576 |
|
|
2024
Q1 | $921K | Sell |
58,930
-14,829
| -20% | -$232K | 0.02% | 451 |
|
|
2023
Q4 | $1.1M | Buy |
73,759
+22,627
| +44% | +$338K | 0.03% | 385 |
|
|
2023
Q3 | $826K | Buy |
51,132
+34,289
| +204% | +$554K | 0.02% | 424 |
|
|
2023
Q2 | $699K | Sell |
16,843
-983
| -6% | -$40.8K | 0.02% | 477 |
|
|
2023
Q1 | $1.07M | Sell |
17,826
-299
| -2% | -$18K | 0.03% | 318 |
|
|
2022
Q4 | $1.33M | Buy |
18,125
+368
| +2% | +$27K | 0.04% | 259 |
|
|
2022
Q3 | $1.35M | Sell |
17,757
-4,089
| -19% | -$311K | 0.04% | 205 |
|
|
2022
Q2 | $1.52M | Sell |
21,846
-10,189
| -32% | -$708K | 0.04% | 210 |
|
|
2022
Q1 | $2.65M | Sell |
32,035
-2,826
| -8% | -$234K | 0.05% | 183 |
|
|
2021
Q4 | $2.62M | Buy |
34,861
+20,985
| +151% | +$1.58M | 0.05% | 218 |
|
|
2021
Q3 | $1.61M | Buy |
13,876
+3,215
| +30% | +$373K | 0.04% | 249 |
|
|
2021
Q2 | $2.37M | Sell |
10,661
-2,505
| -19% | -$556K | 0.07% | 210 |
|
|
2021
Q1 | $1.74M | Buy |
13,166
+5,837
| +80% | +$771K | 0.07% | 211 |
|
|
2020
Q4 | $1.27M | Sell |
7,329
-1,997
| -21% | -$346K | 0.06% | 201 |
|
|
2020
Q3 | $1.04M | Buy |
9,326
+3,282
| +54% | +$365K | 0.06% | 164 |
|
|
2020
Q2 | $358K | Buy |
6,044
+4,370
| +261% | +$259K | 0.06% | 265 |
|
|
2020
Q1 | $113K | Buy |
1,674
+1,103
| +193% | +$74.5K | 0.06% | 249 |
|
|
2019
Q4 | $48K | Buy |
+571
| New | +$48K | 0.01% | 279 |
|